The latest venture capital, seed, pre-seed, and angel deals for London startups for 29/7/2021 featuring funding details for Vira Health, Flock, and much more.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 28/7/2021 featuring funding details for Bloom & Wild, Patchwork, and much more.
I’ve watched tons of ‘once hot’ startups come and go, from Meerkat to Quibi, WeWork to Theranos. What are some of the things we can learn as Founders about how to manage our own startups when everyone is telling us how amazing we are? What are some of the pitfalls that come with the new hotness?
£81M in new funding for London startups! The latest venture capital, seed, pre-seed, and angel deals for London startups for 27/7/2021 featuring funding details for Elvie, Peppy Health, and much more
The mental health crisis has a hidden toll on employers; depressed employees miss an increased number of workdays every year, employees with depressions lose 8% of work productivity on average, employees experiencing depression are two times more likely to leave a company than their non-depressed counterparts. With performance, engagement, and absenteeism all affected, companies are addressing the importance of providing mental health services to employees. Oliva is an online mental health platform that is designed for the needs of employers so that they can adequately address the mental well-being of their employees. The company uses a research-backed care model to provide service to employees rather than just connecting them with a therapy provider. Sessions can seamlessly be booked, with a slack integration, in just a few clicks where the employee is connected to a vetted specialist that is a part of the Oliva network and the employee is further supported by an in-house care team. Oliva also provides management training so that potential mental health issues can be detected early before they have a significant impact on operations. London TechWatch caught up with CEO, serial entrepreneur, and Cofounder Javier Suarez to learn how his personal experience running a startup led to founding this company, the importance of investing in employee mental health, the company’s strategic plans, recent round of funding, and much, much more.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 26/7/2021 featuring funding details for Walking on Earth, Sproutl, and much more.
10 fundings; £230M+ in new funding for London startups announced! London Tech News for the week ending 24/7 featuring news for Worldr, Percent, and much, much more.
The European Tech Weekly Notable Startup Funding Report takes on a trip across various ecosystems in Europe, highlighting some of the notable funding activity in the various markets that we track. The notable European Tech startup fundings for the week ending 24/7/21 featuring funding details for Choco, Wunderflats, and nine other European fundings that you absolutely need to know about.
mRNA science has shown the power of using an operating system framework for drug discovery and development with the successful COVID vaccine developments from Pfizer and Moderna. Integrating technology into the drug design process introduces unparalleled speed and flexibility. Kuano is using AI, quantum chemistry, and medical science to focus on enzyme reactions, a key factor in drug development, to develop novel therapeutics. The company is able to model enzyme reactions with unprecedented specificity allowing the drug makers to acquire the building blocks for pharmaceuticals that will address some of our most pressing and challenging diseases. London TechWatch caught up with Cofounder and CEO Vid Stojevic to learn more about how the Kuano changes the paradigm of drug development, the company’s strategic plans, and recent round of funding from ACF Investors, o2h Ventures, and a syndicate of Cambridge, London and UK-based angel investors.
The latest venture capital, seed, pre-seed, and angel deals for London startups for 23/7/2021 featuring funding details for YOOBIC, Lottie, and much more.